Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans
Kevin W. Ng, Nikhil Faulkner, Georgina H. Cornish, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1024-1042.e21
Open Access | Times Cited: 1432
T cell response to SARS-CoV-2 infection in humans: A systematic review
Madhumita Shrotri, May C I van Schalkwyk, Nathan Post, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245532-e0245532
Open Access | Times Cited: 351
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection
Daniel M. Altmann, Rosemary J. Boyton
Science Immunology (2020) Vol. 5, Iss. 49
Open Access | Times Cited: 277
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Yannick Galipeau, Matthew Greig, George Liu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 242
S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
Phuong Nguyen‐Contant, A. Karim Embong, Preshetha Kanagaiah, et al.
mBio (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 208
Compromised SARS-CoV-2-specific placental antibody transfer
Caroline Atyeo, Krista M. Pullen, Evan A. Bordt, et al.
Cell (2020) Vol. 184, Iss. 3, pp. 628-642.e10
Open Access | Times Cited: 196
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases
David Baker, C A K Roberts, Gareth Pryce, et al.
Clinical & Experimental Immunology (2020) Vol. 202, Iss. 2, pp. 149-161
Open Access | Times Cited: 194
Natural history of COVID-19 and therapeutic options
Philippe Gautret, Matthieu Million, Pierre‐André Jarrot, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1159-1184
Closed Access | Times Cited: 143
Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures
Jacob D. Galson, Sebastian Schaetzle, Rachael Bashford-Rogers, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 136
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
Natalia Ortega, Marta Ribes, Marta Vidal, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 132
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
Savannah E. Butler, Andrew R. Crowley, Harini Natarajan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 115
Convalescent Plasma Therapy for COVID-19: State of the Art
Daniele Focosi, Arthur O. Anderson, Julian W. Tang, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 4
Open Access | Times Cited: 126
The immuno-oncological challenge of COVID-19
Lisa Derosa, Cléa Melenotte, Frank Griscelli, et al.
Nature Cancer (2020) Vol. 1, Iss. 10, pp. 946-964
Open Access | Times Cited: 116
Covid-19: Do many people have pre-existing immunity?
Peter Doshi
BMJ (2020), pp. m3563-m3563
Closed Access | Times Cited: 103
Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option
Kevin W. Ng, Jan Attig, William Bolland, et al.
Nature Genetics (2020) Vol. 52, Iss. 12, pp. 1294-1302
Open Access | Times Cited: 94
Antibody response to SARS-CoV-2 infection in humans: a systematic review
Nathan Post, Danielle Eddy, Catherine Huntley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 83
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
Srinivasa Reddy Bonam, Niranjan G. Kotla, Raghvendra A. Bohara, et al.
Nano Today (2020) Vol. 36, pp. 101051-101051
Open Access | Times Cited: 69
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
Alberto Beretta, Martin Cranage, Donato Zipeto
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 61
SARS-CoV-2 virus and antibodies in front-line Health Care Workers in an acute hospital in London: preliminary results from a longitudinal study
Catherine Houlihan, Nina Vora, Thomas Byrne, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 54
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Anna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3989-3989
Open Access | Times Cited: 48
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
Sophie Uyoga, Ifedayo Adetifa, Henry Karanja, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 44
Sharing a household with children and risk of COVID-19: a study of over 300 000 adults living in healthcare worker households in Scotland
Rachael Wood, Emma C. Thomson, Robert M. Galbraith, et al.
Archives of Disease in Childhood (2021) Vol. 106, Iss. 12, pp. 1212-1217
Open Access | Times Cited: 37
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large metropolitan region
Marc Emmenegger, Elena De Cecco, David Lamparter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 37
The impact of school reopening on the spread of COVID-19 in England
Matt J. Keeling, Michael J. Tildesley, Benjamin D. Atkins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 36
Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
Ramachandran Vignesh, Esaki M. Shankar, Vijayakumar Velu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top